Cantor Fitzgerald analyst Charles Duncan maintains Clene (NASDAQ:CLNN) with a Buy and raises the price target from $6 to $8.
Cantor Fitzgerald Maintains Buy on Clene, Raises Price Target to $8
Cantor Fitzgerald analyst Charles Duncan maintains Clene (NASDAQ:CLNN) with a Buy and raises the price target from $6 to $8.